AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $1.16 billion. The enterprise value is $447.98 million.
| Market Cap | 1.16B |
| Enterprise Value | 447.98M |
Important Dates
The next confirmed earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 292.78 million shares outstanding. The number of shares has decreased by -8.15% in one year.
| Shares Outstanding | 292.78M |
| Shares Change (YoY) | -8.15% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 28.09% |
| Owned by Institutions (%) | 43.65% |
| Float | 191.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 27.47 |
| PS Ratio | 30.57 |
| Forward PS | 24.03 |
| PB Ratio | 1.01 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.33, with a Debt / Equity ratio of 0.06.
| Current Ratio | 7.33 |
| Quick Ratio | 6.86 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.40% and return on invested capital (ROIC) is -19.39%.
| Return on Equity (ROE) | -12.40% |
| Return on Assets (ROA) | -9.70% |
| Return on Capital (ROIC) | -19.39% |
| Revenue Per Employee | $64,889 |
| Profits Per Employee | -$249,826 |
| Employee Count | 586 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -27.63M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.63% in the last 52 weeks. The beta is 0.36, so ABCL's price volatility has been lower than the market average.
| Beta (1Y) | 0.36 |
| 52-Week Price Change | -44.63% |
| 50-Day Moving Average | 4.67 |
| 200-Day Moving Average | 5.16 |
| Relative Strength Index (RSI) | 36.04 |
| Average Volume (30 Days) | 1,330,764 |
Short Selling Information
The latest short interest is 23.59 million, so 8.06% of the outstanding shares have been sold short.
| Short Interest | 23.59M |
| Short Previous Month | 23.04M |
| Short % of Shares Out | 8.06% |
| Short % of Float | 12.30% |
| Short Ratio (days to cover) | 17.89 |
Income Statement
In the last 12 months, ABCL had revenue of $38.03 million and -$146.40 million in losses. Loss per share was -$0.51.
| Revenue | 38.03M |
| Gross Profit | 38.03M |
| Operating Income | -237.21M |
| Pretax Income | -174.03M |
| Net Income | -146.40M |
| EBITDA | -143.14M |
| EBIT | -174.03M |
| Loss Per Share | -$0.51 |
Balance Sheet
The company has $785.59 million in cash and $71.22 million in debt, giving a net cash position of $714.36 million or $2.44 per share.
| Cash & Cash Equivalents | 785.59M |
| Total Debt | 71.22M |
| Net Cash | 714.36M |
| Net Cash Per Share | $2.44 |
| Equity / Book Value | 1.15B |
| Book Value Per Share | 3.94 |
| Working Capital | 752.97M |
Cash Flow
In the last 12 months, operating cash flow was -$43.88 million and capital expenditures -$76.95 million, giving a free cash flow of -$120.82 million.
| Operating Cash Flow | -43.88M |
| Capital Expenditures | -76.95M |
| Free Cash Flow | -120.82M |
| FCF Per Share | -$0.42 |
Margins
Gross margin is 100.00%, with operating and profit margins of -623.82% and -385.00%.
| Gross Margin | 100.00% |
| Operating Margin | -623.82% |
| Pretax Margin | -457.67% |
| Profit Margin | -385.00% |
| EBITDA Margin | -376.42% |
| EBIT Margin | -457.67% |
| FCF Margin | -317.75% |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.15% |
| Shareholder Yield | 8.15% |
| Earnings Yield | -12.60% |
| FCF Yield | -10.39% |
Analyst Forecast
The average price target for ABCL is $19.00, which is 378.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.00 |
| Price Target Difference | 378.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 36.86% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 2.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.59 |
| Piotroski F-Score | 2 |